TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Novo Nordisk Scandinavia AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,030,467
|
1,817,185
|
1,103,660 |
| Financial expenses |
1,531
|
406
|
81 |
| Earnings before taxes |
80,084
|
72,424
|
48,411 |
| EBITDA |
73,286
|
67,397
|
47,289 |
| Total assets |
397,835
|
493,935
|
423,202 |
| Current assets |
396,029
|
493,674
|
422,854 |
| Current liabilities |
208,842
|
323,974
|
288,191 |
| Equity capital |
145,335
|
129,001
|
94,202 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
123
|
110
|
115 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.5%
|
26.1%
|
22.3% |
| Turnover per employee |
16,508
|
16,520
|
9,597 |
| Profit as a percentage of turnover |
3.9%
|
4.0%
|
4.4% |
| Return on assets (ROA) |
20.5%
|
14.7%
|
11.5% |
| Current ratio |
189.6%
|
152.4%
|
146.7% |
| Return on equity (ROE) |
55.1%
|
56.1%
|
51.4% |
| Change turnover |
180,516
|
635,213
|
217,867 |
| Change turnover % |
10%
|
54%
|
25% |
| Chg. No. of employees |
13
|
-5
|
9 |
| Chg. No. of employees % |
12%
|
-4%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.